PIM2 and cancer: Whatever the reasons for the differential effects of PIM-2 are, this study suggests that while targeting PIM-2's kinase activity might indeed be beneficial chemotherapeutically in certain malignancies, it might be devastating in other cancers in which activating PIM-2 might actually reduce the malignant phenotype.